Selected article for: "heavy chain and HIV bnabs"

Author: Roskin, Krishna M.; Jackson, Katherine J. L.; Lee, Ji-Yeun; Hoh, Ramona A.; Joshi, Shilpa A.; Hwang, Kwan-Ki; Bonsignori, Mattia; Pedroza-Pacheco, Isabela; Liao, Hua-Xin; Moody, M. Anthony; Fire, Andrew Z.; Borrow, Persephone; Haynes, Barton F.; Boyd, Scott D.
Title: Aberrant B cell repertoire selection associated with HIV neutralizing antibody breadth
  • Cord-id: 1d3v87km
  • Document date: 2020_1_20
  • ID: 1d3v87km
    Snippet: A goal of HIV vaccine development is to elicit antibodies with neutralizing breadth. Broadly neutralizing antibodies (bNAbs) to HIV often have unusual sequences with long heavy-chain complementarity-determining region loops, high somatic mutation rates and polyreactivity. A subset of HIV-infected individuals develops such antibodies, but it is unclear whether this reflects systematic differences in their antibody repertoires or is a consequence of rare stochastic events involving individual clon
    Document: A goal of HIV vaccine development is to elicit antibodies with neutralizing breadth. Broadly neutralizing antibodies (bNAbs) to HIV often have unusual sequences with long heavy-chain complementarity-determining region loops, high somatic mutation rates and polyreactivity. A subset of HIV-infected individuals develops such antibodies, but it is unclear whether this reflects systematic differences in their antibody repertoires or is a consequence of rare stochastic events involving individual clones. We sequenced antibody heavy-chain repertoires in a large cohort of HIV-infected individuals with bNAb responses or no neutralization breadth and uninfected controls, identifying consistent features of bNAb repertoires, encompassing thousands of B cell clones per individual, with correlated T cell phenotypes. These repertoire features were not observed during chronic cytomegalovirus infection in an independent cohort. Our data indicate that the development of numerous B cell lineages with antibody features associated with autoreactivity may be a key aspect in the development of HIV neutralizing antibody breadth.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute illness: 1, 2, 3, 4, 5, 6
    • absence presence and low frequency: 1, 2, 3, 4, 5, 6
    • absence presence and luc reporter: 1
    • activation marker and local site: 1
    • acute illness and low frequency: 1, 2, 3
    • acute illness and low threshold: 1
    • additional reference and low frequency: 1
    • local site and low frequency: 1, 2